Mounjaro 15mg UK 2026: Results, Side Effects & Costs

You've worked your way up the doses. Maybe you're on 10mg and the scales have gone quiet for a few weeks, or you're sitting at 12.5mg wondering whether the last step is worth taking. Either way, the question people bring to us about Mounjaro 15mg is almost always the same one: will it actually make a difference, or am I just paying more for the same result?

It's a fair question, and the honest answer has more texture than most pharmacy pages give it.

What Mounjaro 15mg actually is

Mounjaro 15mg is the top strength of tirzepatide, a once-weekly injection that acts on two gut hormone receptors at once, GIP and GLP-1. If you want the mechanism in plain terms, we've covered how GLP-1 medications work elsewhere.

The Summary of Product Characteristics sets out the ladder clearly. Everyone starts at 2.5mg once weekly. After four weeks the dose goes up to 5mg. From there, increases happen in 2.5mg steps, with a minimum of four weeks on each dose before moving up. The licensed maintenance doses are 5mg, 10mg and 15mg, and 15mg once weekly is the maximum.

That means nobody starts on 15mg, and nobody skips to it. The shortest possible route runs 2.5 → 5 → 7.5 → 10 → 12.5 → 15, which takes at least 20 weeks of treatment before the first 15mg injection. Most people take considerably longer, because holding a dose for two or three months is common and often sensible.

Each KwikPen holds four weekly doses of 0.6ml. If you've been on Mounjaro since before the pen redesign, you may remember the fifth-dose question, which we wrote about when the KwikPen changed.

How much more weight do people lose on Mounjaro 15mg?

The numbers exist, and a lot of marketing copy quietly rounds them in its own favour.

The trial that anchors all of this is SURMOUNT-1, a 72-week study in 2,539 adults with obesity or overweight and no type 2 diabetes, published in the New England Journal of Medicine. It compared 5mg, 10mg and 15mg against placebo. Lilly's summary of the published results reports two ways of reading the data. The treatment-regimen estimand counts everyone regardless of whether they stayed on the drug, which is closer to real life. The efficacy estimand looks only at the period before people stopped, which is closer to a best case.

Look down the treatment-regimen column. The step from 5mg to 10mg buys about four and a half percentage points of average weight loss. The step from 10mg to 15mg buys about one and a half.

That's not nothing. On a 100kg starting weight, 1.4 percentage points is roughly 1.4kg, and the proportion of people reaching the 20% mark climbs from half to well over half. But it's a smaller return than the earlier steps, and it explains why so many clinicians treat 10mg as a good place to stay rather than a waypoint.

Waist measurements tell a similar story: 17.7cm off at 10mg, 18.5cm at 15mg. Body composition held up well across the board, with participants losing about three times as much fat mass as lean mass.

Who Mounjaro 15mg is actually for

A prescriber will usually consider the step up to 15mg when three things are true at once. You've had at least four weeks at 12.5mg. Your side effects are mild or settling rather than getting worse. And your weight loss has slowed or stopped at a point where you and your clinician agree there's still meaningful benefit to be had.

The licence also builds in a checkpoint that's worth knowing about. If you haven't lost at least 5% of your starting body weight six months after reaching your highest tolerated dose, the SmPC says a decision is needed on whether continuing makes sense for you. That's a prompt to review, not an automatic stop, and it applies whatever dose you've landed on.

There are also good reasons to hold where you are. If you're still losing weight steadily at 10mg, going higher adds cost and side-effect risk for a benefit you're already getting. If you're close to a weight you're happy with, a maintenance dose is usually the better conversation. And if nausea or reflux at 12.5mg is already shaping what you eat and how you feel on injection day, adding 2.5mg tends to make that worse, not better.

One thing we'd gently push back on: the idea that reaching 15mg is an achievement. It's a clinical decision about how much medication your body needs to do a job, and needing less of it is a perfectly good outcome.

Side effects at 15mg: what actually changes

The dose-by-dose fear stories usually get this backwards. In the pooled weight-management trials reported in the SmPC, the overall rate of gastrointestinal side effects barely moves across the doses: 55.6% at 5mg, 55.8% at 10mg, and 55.6% at 15mg, against 29.7% on placebo. Nausea specifically was 24.6%, 29.0% and 28.0%. Diarrhoea ran 18.7%, 20.8% and 22.5%.

So the chance of having gut symptoms at all is not much higher at the top dose. What does change is how well people tolerate them. The proportion who stopped treatment permanently because of a gastrointestinal side effect was 1.9% at 5mg, 3.3% at 10mg and 4.3% at 15mg. Symptoms that were manageable at a lower dose become the thing that ends treatment for a small but growing minority.

Two other effects are worth naming. Hair loss was reported by 4.9% of people on tirzepatide across the weight-management trials, against 1.0% on placebo, and it was usually mild with most people recovering while still on treatment. We've written more on hair shedding during weight loss if that's a concern. And because tirzepatide slows stomach emptying, it can reduce how well the contraceptive pill works. MHRA guidance is to add a barrier method for four weeks after starting Mounjaro and for four weeks after any dose increase, or to switch to a method the medication doesn't affect, such as the coil or implant. That applies to the increase to 15mg the same as every step before it, and it's the detail patients most often tell us nobody mentioned.

Serious reactions are uncommon but not trivial. Persistent, severe upper abdominal pain that radiates to the back needs urgent assessment, because acute pancreatitis has been reported with tirzepatide. Our fuller guide to Mounjaro side effects covers what's normal, what settles, and what warrants a call.

What Mounjaro 15mg costs in the UK

Private prices for the 15mg pen sit at the top of almost every provider's list, because most UK pharmacies price tirzepatide by strength. The higher the dose, the more you pay, and the jump between 10mg and 15mg is often the steepest on the ladder.

When you're comparing, three details change the real number more than the headline price does.

The first is whether the quoted figure covers four weeks or a single pen, since one pen contains four weekly doses and those two things should match but occasionally don't. The second is what happens to your price when you increase your dose mid-plan, because some providers charge the new rate immediately and others hold your current price to the end of the cycle. The third is whether clinical review, delivery and ongoing support are included or billed separately.

We keep a running comparison of what Mounjaro costs across UK providers, and a separate piece on how to choose between them that looks past price alone.

Counterfeit 15mg pens: what the MHRA found

In February 2026 the MHRA contacted patients about fake Mounjaro KwikPen 15mg pens dispensed by a pharmacy in Birmingham. Every affected pen identified was a 15mg pen carrying batch number D873576, which is a legitimate batch number for genuine 7.5mg pens. Eli Lilly had received five reports of faulty pens, and in all but one case the dose knob came off during use.

Testing confirmed the fake pens did contain tirzepatide. The problem was that nobody knew where or how they were made, so sterility couldn't be guaranteed. The MHRA's advice was to stop using any 15mg pen with that batch number, keep it somewhere safe, and report it. If you have a 15mg pen with a different batch number, it's fine to carry on as prescribed.

There's a reason this landed on the top dose. Fifteen milligrams is the most expensive strength and the one people are most tempted to source cheaply, which makes it the most attractive target for counterfeiting. Buying from a pharmacy registered with the General Pharmaceutical Council, with a named superintendent pharmacist and a prescriber who has actually assessed you, is the single most useful thing you can do about that risk. Our guide to whether Mounjaro is safe goes into the wider picture.

If you ever suspect a pen is faulty or fake, don't try to extract the medicine from it. Report it through the MHRA's Yellow Card scheme and speak to your prescriber.

Staying on 15mg, stepping down, or stopping

Some people stay on 15mg for months. Others reach their target and drop back to a lower dose to hold it. Both are legitimate, and neither is a sign of anything going wrong.

Stepping down usually goes the way you came up, one increment at a time, which gives appetite room to return gradually rather than all at once. Tirzepatide has a half-life of about five days, so the medication clears over roughly a month after the last injection. That's the window in which hunger typically comes back, and it's why an abrupt stop tends to feel harder than a planned taper. We've written about what happens when you stop taking Mounjaro in more detail.

Whatever you decide, protein intake and resistance training matter more at this stage than at any other. Fifteen milligrams suppresses appetite hard, and eating enough to protect muscle takes deliberate effort when you're not hungry. Our guide to maintaining muscle on GLP-1 treatment covers the practical side.

If you're earlier in treatment and 15mg still feels a long way off, the full Mounjaro dosage schedule walks through each step, and our page on Mounjaro 10mg covers the dose most people reach first.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.